Cargando…

Dynamics of soluble vascular endothelial growth factor receptors and their ligands in aqueous humour during ranibizumab for age-related macular degeneration

BACKGROUND: Intravitreal ranibizumab injection (IRI) is effective for patients with exudative age-related macular degeneration (AMD) and decreases intraocular levels of vascular endothelial growth factor (VEGF), but VEGF receptor intraocular dynamics after IRI are unclear. Therefore, we evaluated ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Motohashi, Ryosuke, Noma, Hidetaka, Yasuda, Kanako, Kotake, Osamu, Goto, Hiroshi, Shimura, Masahiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280338/ https://www.ncbi.nlm.nih.gov/pubmed/30534004 http://dx.doi.org/10.1186/s12950-018-0203-x

Ejemplares similares

Intravitreal ranibizumab reduced ocular blood flow and aqueous cytokine levels and improved retinal morphology in patients with diabetic macular edema
por: Mizui, Toru, et al.
Publicado: (2020)

Optic neuritis and acute anterior uveitis associated with influenza A infection: a case report
por: Nakagawa, Hayate, et al.
Publicado: (2017)

Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
por: Otawa, Taro, et al.
Publicado: (2022)

Retinal Microcirculation and Cytokines as Predictors for Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Branch Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2020)

Effects of Intravitreal Ranibizumab Injection to Treat Macular Edema due to Central Retinal Vein Occlusion on Choroidal Findings and Functional-Morphological Parameters
por: Yasuda, Kanako, et al.
Publicado: (2023)

Effects of Intravitreal Ranibizumab Injection on Peripheral Retinal Microcirculation and Cytokines in Branch Retinal Vein Occlusion with Macular Edema
por: Yasuda, Kanako, et al.
Publicado: (2023)

Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema
por: Noma, Hidetaka, et al.
Publicado: (2021)

Cytokines and the Pathogenesis of Macular Edema in Branch Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2019)

Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
por: Mashima, Asako, et al.
Publicado: (2019)

Changes in multiple cytokine concentrations in the aqueous humour of neovascular age-related macular degeneration after 2 months of ranibizumab therapy
por: Sakamoto, Shinichi, et al.
Publicado: (2018)

New individualized aflibercept treatment protocol for branch retinal vein occlusion with macular edema
por: Noma, Hidetaka, et al.
Publicado: (2023)

Anti-Vascular Endothelial Growth Factor Therapy with or Without Initial Steroid Therapy for Macular Edema in Branch Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2023)

Changes of retinal flow volume after intravitreal injection of bevacizumab in branch retinal vein occlusion with macular edema: a case series
por: Noma, Hidetaka, et al.
Publicado: (2016)

Aqueous humour cytokine changes during a loading phase of intravitreal ranibizumab or dexamethasone implant in diabetic macular oedema
por: Podkowinski, Dominika, et al.
Publicado: (2019)

Cytokines and Pathogenesis of Central Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2020)

Distinct Aqueous Humour Cytokine Profiles of Patients with Pachychoroid Neovasculopathy and Neovascular Age-related Macular Degeneration
por: Terao, Nobuhiro, et al.
Publicado: (2018)

Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degeneration
por: Arai, Yusuke, et al.
Publicado: (2020)

Glycolysis in Patients with Age-Related Macular Degeneration
por: Yokosako, Kanako, et al.
Publicado: (2014)

Role of ranibizumab in management of macular degeneration
por: Singh, Rishi P, et al.
Publicado: (2007)

Relationship between retinal blood flow and cytokines in central retinal vein occlusion
por: Noma, Hidetaka, et al.
Publicado: (2020)

Soluble HLA in the Aqueous Humour of Uveal Melanoma Is Associated with Unfavourable Tumour Characteristics
por: Wierenga, Annemijn P. A., et al.
Publicado: (2019)

Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006)

On Inflammation of the Membrane of the Aqueous Humour of the Eye
por: Watson, Alexander
Publicado: (1845)

Treatment of age-related macular degeneration: focus on ranibizumab
por: Spitzer, Martin S, et al.
Publicado: (2008)

Endocannabinoids in aqueous humour of patients with or without diabetes
por: Richardson, Patrick, et al.
Publicado: (2020)

Repeated Evacuation of the Aqueous Humour in Diseases of the Eye
por: Sperino, Casimir
Publicado: (1866)

Penetration of Enrofloxacin in Aqueous Humour of Avian Eyes
por: Fuchs, Katrin, et al.
Publicado: (2022)

Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration
por: Suzuki, Misa, et al.
Publicado: (2014)

Aqueous humour concentrations of PEDF and Erythropoietin are not influenced by subthreshold micropulse laser treatment of diabetic macular edema
por: Midena, Edoardo, et al.
Publicado: (2019)

Study of aqueous humour inflammatory mediators’ levels in a cohort of Egyptian patients with diabetic macular oedema
por: Gomaa, Amir Ramadan, et al.
Publicado: (2023)

Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
por: Hurley, Susan F, et al.
Publicado: (2008)

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Observations on the Effects of Evacuating the Aqueous Humour in Inflammation of the Eyes
Publicado: (1808)

Proteomic analysis of the aqueous humour in eyes with pseudoexfoliation syndrome
por: Botling Taube, Amelie, et al.
Publicado: (2019)

Association of Keratin 8 Level in Aqueous Humor With Outcomes of Intravitreal Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration
por: Shin, Joo Youn, et al.
Publicado: (2022)

Ranibizumab plus fufang xueshuantong capsule versus ranibizumab alone for exudative age-related macular degeneration
por: Pan, Hai-Tao, et al.
Publicado: (2020)

Sub-threshold micropulse laser treatment reduces inflammatory biomarkers in aqueous humour of diabetic patients with macular edema
por: Midena, Edoardo, et al.
Publicado: (2019)

Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
por: Fong, Angie HC, et al.
Publicado: (2013)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
por: Dervenis, Nikolaos, et al.
Publicado: (2016)

Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
por: Karagiannis, Dimitrios A, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_kequvekv8leh55lahtl01f42u5